MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/mcp.M600170-MCP200 on July 13, 2006.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M600170-MCP200v1
5/9/1638    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellmark, P.
Right arrow Articles by Borrebaeck, C. A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellmark, P.
Right arrow Articles by Borrebaeck, C. A. K.
Molecular & Cellular Proteomics 5:1638-1646, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.

Research

Identification of Protein Expression Signatures Associated with Helicobacter pylori Infection and Gastric Adenocarcinoma Using Recombinant Antibody Microarrays*

Peter Ellmark{ddagger}, Johan Ingvarsson{ddagger}, Anders Carlsson{ddagger}, B. Samuel Lundin§, Christer Wingren{ddagger} and Carl A. K. Borrebaeck{ddagger},¶

From the {ddagger} Department of Immunotechnology, Lund University, BMC D13, SE-22184 Lund, Sweden and § Institute of Biomedicine, Department of Microbiology and Immunology, Göteborg University, 40530 Göteborg, Sweden

Antibody microarray based technology is a powerful emerging tool in proteomics, target discovery, and differential analysis. Here, we report the first study where recombinant antibody fragments have been used to construct large scale antibody microarrays, composed of 127 different antibodies against mostly immunoregulatory antigens. The arrays were based on single framework recombinant antibody fragments (SinFabs) designed for high on-chip stability and functionality and were used for the analysis of malignant and normal stomach tissue samples from Helicobacter pylori-positive and -negative patients. Our results demonstrate that distinct tumor- as well as infection-associated protein expression signatures could be identified from these complex tissue proteomes, as well as biomarkers such as IL-9, IL-11, and MCP-4, previously not found in these diseases. In a longer perspective, this study may improve the understanding of H. pylori-induced stomach cancer and lead to development of improved diagnostics.

To whom correspondence should be addressed. Tel.: 46-46-222-9613; Fax: 46-46-222-4200; E-mail: carl.borrebaeck{at}immun.lth.se




This article has been cited by other articles:


Home page
 J. Exp. Med.Home page
E. E. Forbes, K. Groschwitz, J. P. Abonia, E. B. Brandt, E. Cohen, C. Blanchard, R. Ahrens, L. Seidu, A. McKenzie, R. Strait, et al.
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity
J. Exp. Med., April 14, 2008; 205(4): 897 - 913.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.